Researchers developed a non-invasive test to detect chronic inflammation by analyzing extracellular vesicles in blood and urine. They identified specific microRNAs and membrane proteins to distinguish kidney inflammation from other types, providing clues to the source of chronic inflammation.
Researchers have discovered a link between CDK1 protein activity and breast cancer response to CDK4/6 inhibitors. Higher CDK1 activity is associated with more aggressive cancer and poorer outcomes. The study suggests that tracking CDK1 activity could help doctors identify patients most likely to benefit from targeted therapy.
Researchers developed ChatBiobank, a web tool using the 3M framework to streamline biobanking processes for multi-omics applications. The tool achieved high accuracy in evaluating 230 questions, with 98.7% of outputs meeting professional-acceptability standards.
Researchers have developed a blood test that can identify brain injury severity in patients, helping clinicians escalate care. The test uses two proteins, GFAP and UCH-L1, which rise in the bloodstream after injury, and can differentiate between patients with acute brain injury and those with no evidence of pathology.
A consensus statement has been reached on the recognition, diagnosis, and management of traumatic brain injury in first responders. The guidelines emphasize shared organizational responsibility, supportive reporting processes, and occupation-specific return to duty progression to improve recovery outcomes and reduce stigma.
Artificial intelligence can match human doctors in certain tasks, but human doctors are essential for making complex decisions about patient care. AI may identify a patient's medical condition, but human doctors must consider individual circumstances and make choices that work in the patient's best interest.
Researchers developed a rapid urine test to detect invasive aspergillosis, with high sensitivity and specificity rates. The test was cleared by the FDA and has shown promise in identifying cases among patients with weakened immune systems.
Researchers developed an AI model that accurately flags heart transplant rejection by combining electrocardiogram readings with blood test results, potentially sparing patients from invasive biopsies. The model correctly identified 94% of patients without rejection and incorrectly flagged 19 patients with blood test results.
A blood test that compares two molecules in the blood can accurately distinguish between bacterial and viral infections in newborn babies with fever. The test showed a high sensitivity and specificity, and could potentially improve treatment and reduce unnecessary antibiotic use.
A novel multimodal auditory assessment platform combines brain-activity measurements and pupil-response monitoring to evaluate hearing-related disorders. The platform has been implemented for data collection and has shown promise in identifying features associated with abnormal auditory sensitivity.
A machine learning system has been developed to identify cancer cells based on their light scattering patterns, achieving high accuracy even with cells having similar morphology. The system, which uses dark-field microscopy and machine learning algorithms, has shown promise in distinguishing between different types of cancer cells.
Researchers at Tulane University have developed a diagnostic platform that can identify the precise species of bacteria causing NTM lung disease infections within four hours. The platform, called CANDI, uses mucus from the lungs and other respiratory fluids to test for up to 15 clinically relevant species and subspecies of NTM bacteria.
This technology combines electrocardiogram signals and electrical impedance tomography data to aid in the diagnosis and treatment of cardiac and pulmonary conditions. The simultaneous acquisition of ECG and EIT data provides precise cardiac timing and enhances EIT image reconstructions.
Researchers developed a low-cost smartphone attachment to capture diagnostic-quality eye images, which can be reviewed remotely by ophthalmologists. Community health workers and remote ophthalmologists agreed on 96% of cataract diagnoses, challenging the assumption that specialist presence is necessary for accurate screening.
Researchers discovered that cancer cells with RET mutations produce higher levels of the OPG protein, which disrupts bone renewal and blocks destruction, favoring bone accumulation. Measuring OPG levels via blood tests could identify and monitor patients with aggressive disease.
Prostate cancer affects 1 in 8 men, with 60% diagnosed in men 65 and older. Clinical trials like Alliance's help improve early detection and treatment, reducing mortality rates by half since 1993. These trials also explore new treatments and survivorship strategies.
A large population-based study found that emergency diagnoses are common across multiple conditions, including Parkinson’s disease and coronary heart disease, and are consistently associated with worse outcomes. The study suggests that emergency diagnosis is a common phenomenon across diverse diseases and is linked to higher mortality ...
Researchers at the University of Toledo have developed a rapid blood screening method to detect elevated bile acids, an early but overlooked marker of liver disease. The test, which has been patented, can accurately identify individuals with high bile acids and has the potential to save lives by catching liver disease early.
Celiac disease is a chronic autoimmune disorder caused by gluten intolerance, characterized by small intestine damage and malabsorption. Symptoms include diarrhea, abdominal pain, fatigue, and weight loss, with accurate testing and early treatment available to prevent complications.
A recent study published in JAMA Network Open finds a strong association between gestational diabetes and an increased risk of postpartum cardiovascular, kidney, and metabolic disorders. The research highlights the importance of monitoring and managing gestational diabetes to prevent long-term health consequences for mothers.
Researchers identified seven proteins in the blood that can help diagnose Alzheimer's disease more accurately, improving treatment choices and future research. The new blood-based tests provide a clearer picture of the disease, allowing for earlier detection and better patient outcomes.
Researchers have developed a machine learning model that can help clinicians assess uncertain variants in prenatal genetic testing, providing more accurate diagnoses and clearer information for families. The approach uses tissue-agnostic episignatures to overcome limitations in epigenetic testing.
A new study uses mathematical biomarkers to accurately predict prostate cancer patient outcomes and survival, outperforming traditional PSA monitoring. These metrics can inform personalized treatment protocols, enabling more effective adaptive therapy.
A cohort study found nearly 30% of screened patients had health-related social needs, with higher rates among racial and ethnic minority groups and those publicly insured. Inpatient HRSN screening workflows provide support for equitable reach, preserving benefits for patient groups with disproportionately high social needs.
A cohort study revealed racial differences in sonographic evaluation, with a 76% completion rate and excellent cancer exclusion ability in Black women despite fibroids impairing endometrial visibility. Fibroid presence did not hinder cancer detection accuracy.
A randomized clinical trial found video laryngoscopy with a Macintosh blade (VLM) and hyperangulated blade (VLH) to have significantly higher first-pass success rates compared to direct laryngoscopy (DL). The study supports the use of video laryngoscopy as a new standard for routine airway management in adult patients.
Researchers used connected speech analysis to distinguish between nonfluent, logopenic and semantic PPA variants with high accuracy. The study also showed expected atrophy associations and discriminated common neuropathologic classes in an autopsy-confirmed subset.
A decision analytical model and microsimulation study found that expanding alcohol screening and brief interventions in primary care could reduce premature mortality from major alcohol-related causes of death in US adults. By 2030, this expanded approach is projected to decrease annual alcohol-related potential years of life lost by −5...
A new study found that a simple blood test can accurately identify tuberculosis (TB) among patients, which could help save millions of lives and reduce transmission. The test measures a specific marker called ESAT-6 produced by the TB bacteria.
A Tulane University team is using AI to discover new superconductors, which could improve the nation's electrical grid, medical imaging, and quantum computing. The project combines high-fidelity calculations, physics-aware AI, and experimental measurements to accelerate discovery.
A cohort study of Korean patients with lung cancer found that international screening guidelines excluded 64.6% of patients, many without smoking history. Ineligible patients had lower mortality risk than eligible patients, suggesting tailored approaches are necessary to enhance early detection.
A blood test measuring phosphorylated tau 217 (P-tau217) can estimate an individual's risk of developing cognitive impairment over 2, 5, and 10 years. Higher P-tau217 levels are associated with increased risk of progression to cognitive impairment in cognitively unimpaired older adults.
The meeting will explore breakthroughs in diabetes prevention and treatment, as well as innovative approaches to monitoring astronauts' health in space. Researchers will also discuss potential targets for slowing or preventing Alzheimer's disease in people with Down syndrome, and advancements in cervical cancer screening.
A new award will help advance the proof-of-concept work toward commercialization of an at-home HIV test that detects cases not caught by lab tests. The device, called Click Chemistry Amplified Nanopore (CAN) sensing, has shown promising results in early studies.
Researchers propose using the glucose ketone index (GKI) to track metabolic health in non-communicable diseases, which cause three in four deaths worldwide. The GKI measures blood glucose and ketones and may indicate metabolic state, assess long-term nutritional adherence, and support mitochondrial function improvement.
Using the YEARS diagnostic algorithm is as safe as computed tomographic pulmonary angiography (CTPA) for diagnosing suspected pulmonary embolism in patients with cancer. This strategy saved 22% of patients from undergoing CTPA, highlighting its potential to streamline cancer care.
A new study published in JAMA Network Open found an alarming rise in invasive breast cancer among Asian American women over the last two decades. Breast cancer rates are rising among nearly all ethnic groups much faster than any other U.S. group, with Chinese and Vietnamese women experiencing the highest increases.
The AKI-PURIFY survey reveals substantial variability in AKI prevention strategies and KDIGO implementation across ICUs. Despite strong evidence supporting structured preventive approaches, only one-third of respondents reported routine implementation of kidney-protective bundles.
The NHS Clinical Entrepreneur Programme has supported the creation of 691 businesses, generating 5,184 jobs and raising over £1.27 billion in investment. The programme continues to play a critical role in retaining talent within the NHS by enabling clinicians to develop their ventures alongside their clinical careers.
Researchers at Texas A&M University develop a laser technique called TRIP to directly measure quantum forces shaping proteins, enabling accurate prediction of how pharmaceutical drugs interact with them. This breakthrough could lead to the design of medicines tailored to specific diseases, revolutionizing precision medicine.
The study's findings suggest that adults can reduce their likelihood of severe COVID-19-associated outcomes by obtaining a 2025-2026 COVID-19 vaccination. Receipt of the vaccine was associated with additional protection against medically attended COVID-19, including emergency department/urgent care encounters and hospitalizations.
A new blood test, Stockholm3, detected significantly more aggressive prostate cancers than the PSA test without increasing unnecessary follow-ups. The study shows that Stockholm3 identifies 90% of aggressive cancer cases, compared to 74% for PSA.
Researchers at USC are conducting a clinical trial to determine whether mindfulness meditation training can augment the potential benefits of psilocybin therapy for mental well-being and cognitive function. The study will evaluate the effects of psilocybin within an eight-week mindfulness meditation training program.
A cross-sectional study found that colorectal cancer screening participation increased after an organized population screening program, but socioeconomic disparities remained. Younger age groups, single households, and lower-income individuals still lag behind in screening uptake.
Researchers developed a simple blood-based assessment to evaluate high-density lipoprotein's (HDL) cholesterol removal capacity from blood vessel walls. The study linked low HDL function to high-risk coronary plaques, supporting the use of this method for predicting cardiovascular risk.
A recent study found that melanoma disproportionately affects Florida's senior population, with older men experiencing twice as many skin cancer-related deaths as women. The study highlights gaps in prevention and early detection, particularly among men and non-Hispanic populations.
Researchers used an open-source AI model called Mirai to quickly identify high-risk patients and expedite their diagnostic process. This led to a significant reduction in wait times, with some women receiving biopsy results within days of having their mammograms done.
The study found that population-based pathogenic variant testing reveals different subsets of high-risk women than clinical risk factors and polygenic risk scores. This highlights the importance of incorporating PV testing into risk-based screening for breast cancer.
A new laser-based process is set to revolutionize photonics manufacturing by removing manual calibration, which accounts for over half of production costs. The technology promises faster, cheaper, and precise manufacturing at sub-micron tolerances.
A population-based screening trial evaluating a cell-free DNA multicancer early detection test found modest increases in diagnostic delay rates for head and neck, lung, and upper gastrointestinal cancers. These findings suggest that future trials may need to consider system-level spillover effects on healthcare resources.
The American Cancer Society has endorsed two new types of stool tests and recommends limiting the use of blood tests for colorectal cancer screening. The guidelines aim to encourage people to get screened while improving detection rates.
The alliance aims to address the diagnostic gap in rare diseases, leveraging genomics, AI, and technology. BGI Genomics is establishing a national-level rare disease diagnosis center with improved access across Southeast Asia.
A systematic review of point-of-care testing found that rapid tests improve people's understanding of their condition, increase confidence in self-management, and motivate lifestyle changes. This leads to better medication adherence and improved clinical markers, ultimately reducing the risk of serious complications.
A new blood test, called VeloCD, can predict how a patient's illness will progress and how well they will respond to treatment. The test analyzes key markers in the blood that reveal gene expression patterns, allowing for accurate predictions of future clinical states.
Researchers at the University of Texas MD Anderson Cancer Center have identified specific blood-based genomic biomarkers that distinguish inflammatory breast cancer from other subtypes. The study used an improved method of RNA sequencing, called TGIRT sequencing, which allowed for a more comprehensive overview of all RNA types and amou...
Elective MRI screenings may lead to false positives, unnecessary surgery, and emotional harm. Experts argue that detecting certain cancers early is not always beneficial, and the scans can exacerbate anxiety rather than improve quality of life.
Researchers found that accelerated biological aging of a type of white blood cell called monocytes is linked to cognitive and mood-related symptoms of depression. This discovery could lead to earlier diagnosis and personalized treatment for depression, particularly in high-risk populations such as women with HIV.
A new portable device can deliver accurate test results for tuberculosis (TB) in less than half an hour, matching lab accuracy. The MiniDock MTB uses similar technology to COVID-19 tests and detects DNA of mycobacterium tuberculosis, enabling rapid diagnosis and treatment
Researchers developed an AI tool that analyzes routine electronic health records to predict ADHD risk in children years before a typical diagnosis. The model accurately identified risk in children age 5 and older, with consistent performance across patient characteristics.
A new analysis found that prescriptions for curable hepatitis C drugs have declined sharply in recent years, leaving millions without treatment. The researchers urge swift actions to deliver the drugs to those who need them, including increased screening and system-level changes.